I have only taken a couple of casual looks at ACL over the years, but I would rather buy and hold the out-and-out market leader with the track record to match for long periods.
Unless ACL is at a can’t-refuse kind of valuation, or SHL is egregiously valued (which it is not - kind of middle-of-the-road), sticking with the industry top dog is the way to go generally.
Ann: Half Yearly Report and Accounts, page-25
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$24.68 |
Change
-0.760(2.99%) |
Mkt cap ! $11.85B | |||
| Open | High | Low | Value | Volume |
| $25.06 | $25.06 | $24.68 | $35.50M | 1.429M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 972 | $24.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $24.70 | 7700 | 2 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$24.80 |
Change
-0.760 ( 2.41 %) |
||||
| Open | High | Low | Volume | ||
| $25.06 | $25.06 | $24.76 | 104877 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| SHL (ASX) Chart |